Rigel Pharmaceuticals, Inc. (RIGL)
39.65
-6.06
(-13.26%)
USD |
NASDAQ |
Nov 06, 16:00
39.60
-0.05
(-0.13%)
After-Hours: 20:00
Rigel Pharmaceuticals Total Assets (Quarterly) : 521.07M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 521.07M |
| March 31, 2026 | 504.61M |
| December 31, 2025 | 560.62M |
| September 30, 2025 | 242.53M |
| June 30, 2025 | 206.74M |
| March 31, 2025 | 175.97M |
| December 31, 2024 | 493.21M |
| September 30, 2024 | 139.42M |
| June 30, 2024 | 128.41M |
| March 31, 2024 | 126.52M |
| December 31, 2023 | 117.22M |
| September 30, 2023 | 115.32M |
| June 30, 2023 | 117.09M |
| March 31, 2023 | 123.61M |
| December 31, 2022 | 134.28M |
| September 30, 2022 | 115.61M |
| June 30, 2022 | 128.00M |
| March 31, 2022 | 149.07M |
| December 31, 2021 | 167.33M |
| September 30, 2021 | 186.52M |
| June 30, 2021 | 201.60M |
| March 31, 2021 | 215.99M |
| December 31, 2020 | 110.38M |
| September 30, 2020 | 123.06M |
| June 30, 2020 | 138.04M |
| Date | Value |
|---|---|
| March 31, 2020 | 143.36M |
| December 31, 2019 | 147.57M |
| September 30, 2019 | 156.06M |
| June 30, 2019 | 156.16M |
| March 31, 2019 | 172.78M |
| December 31, 2018 | 139.11M |
| September 30, 2018 | 123.17M |
| June 30, 2018 | 141.22M |
| March 31, 2018 | 98.81M |
| December 31, 2017 | 119.11M |
| September 30, 2017 | 71.25M |
| June 30, 2017 | 85.48M |
| March 31, 2017 | 101.33M |
| December 31, 2016 | 78.13M |
| September 30, 2016 | 88.64M |
| June 30, 2016 | 99.32M |
| March 31, 2016 | 108.28M |
| December 31, 2015 | 131.75M |
| September 30, 2015 | 139.17M |
| June 30, 2015 | 148.35M |
| March 31, 2015 | 165.69M |
| December 31, 2014 | 154.14M |
| September 30, 2014 | 163.22M |
| June 30, 2014 | 182.43M |
| March 31, 2014 | 203.29M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cytokinetics, Inc. | 1.825B |
| Inovio Pharmaceuticals, Inc. | 49.39M |
| United Therapeutics Corp. | 7.034B |
| Verastem, Inc. | 206.51M |
| Marker Therapeutics, Inc. | 14.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 95.64M |
| Shareholders Equity (Quarterly) | 425.42M |
| Debt to Equity Ratio | 0.0939 |
| Current Ratio | 1.941 |
| Net Debt Paydown Yield | 0.58% |